Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia

References

• Shibata N, Miyamoto N, Nagai K, et al. Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands. Cancer Sci. 2017;108(8):1657–1666. doi:10.1111/cas.13284
   PubMed Web of Science ®Google Scholar
• Zhang B, Li L, Ho Y, et al. Heterogeneity of leukemia-initiating capacity of chronic myelogenous leukemia stem cells. J Clin Invest. 2016;126(3):975–991. doi:10.1172/JCI79196
   PubMed Web of Science ®Google Scholar
• Ales M, Scaramucci L, Niscola P, et al. IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. Leuk Res. 2010;34(2):2009–2010. doi:10.1016/j.leukres.2009.07.014
   Web of Science ®Google Scholar
• Yaya K, Hind D, Meryem Q, Asma Q, Said B, Sellama N. Single nucleotide polymorphisms of multidrug resistance gene 1 (MDR1) and risk of chronic myeloid leukemia. Tumor Biol. 2014;35(11):10969–10975. doi:10.1007/s13277-014-2400-4
   PubMedGoogle Scholar
• Laborde E. Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ. 2010;17(9):1373–1380. doi:10.1038/cdd.2010.80
   PubMed Web of Science ®Google Scholar
• Dusinska M, Staruchova M, Horska A, et al. CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukaemia. Tumor Biol. 2014;7(7):130–137. doi:10.1016/j.tips.2012.09.007
   Google Scholar
• Wu B, Dong D. Human cytosolic glutathione transferases: structure, function, and drug discovery. Trends Pharmacol Sci. 2012;33(12):656–668. doi:10.1016/j.tips.2012.09.007
   PubMed Web of Science ®Google Scholar
• Cummins I, Dixon DP, Freitag-Pohl S, Skipsey M, Edwards R. Multiple roles for plant glutathione transferases in xenobiotic detoxification. Drug Metab Rev. 2011;43(2):266–280. doi:10.3109/03602532.2011.552910
   PubMed Web of Science ®Google Scholar
• Board PG, Menon D. Structure, function and disease relevance of Omega-class glutathione transferases. Arch Toxicol. 2016;90(5):1049–1067. doi:10.1007/s00204-016-1691-1
   PubMed Web of Science ®Google Scholar
• He HR, Zhang XX, Sun JY, et al. Glutathione S-transferase gene polymorphisms and susceptibility to chronic myeloid leukemia. Tumor Biol. 2014;35(6):6119–6125. doi:10.1007/s13277-014-1810-7
   Google Scholar
• Duvoix A, Delhalle S, Blasius R, et al. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem Pharmacol. 2004;68(6):1101–1111. doi:10.1016/j.bcp.2004.05.032
   PubMed Web of Science ®Google Scholar
• Pawlowska E, Blasiak J. DNA repair—a double-edged sword in the genomic stability of cancer cells—the case of chronic myeloid leukemia. Int J Mol Sci. 2015;16(11):27535–27549. doi:10.3390/ijms161126049
   Web of Science ®Google Scholar
• Esposito MT, So CWE. DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis, disease progression, and chemotherapy resistance. Chromosoma. 2014;123(6):545–561. doi:10.1007/s00412-014-0482-9
   PubMed Web of Science ®Google Scholar
• Catana A, Popp RA, Pop M, Porojan MD, Petrisor FM, Pop IV. Genetic polymorphism of DNA repair gene ERCC2/XPD (Arg 156 Arg) (A22541C) and lung cancer risk in Northern Romania. Revista Română de Medicină de Laborator. 2012;20(2):4–6.
   Web of Science ®Google Scholar
• Mitra AK, Singh N, Garg VK, Chaturvedi R, Sharma M, Rath SK. Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population. J Exp Clin Cancer Res. 2009;28(1):104. doi:10.1186/1756-9966-28-104
   Web of Science ®Google Scholar
• Douzi K, Ouerhani S, Menif S, Safra I, Abbes S. Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population. Leuk Lymphoma. 2015;56(6):1856–1862. doi:10.3109/10428194.2014.974045
   PubMed Web of Science ®Google Scholar
• Yetgin S, Yalçin SS. The effect of vitamin D3 on CD34 progenitor cells in vitamin D deficiency rickets. Turk J Pediatr. 2004;46(2):164–166.
   Web of Science ®Google Scholar
• Sorour A, Ayad MW, Kassem H. The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia. Genet Test Mol Biomarkers. 2013;17(3):195–201. doi:10.1089/gtmb.2012.0278
   PubMed Web of Science ®Google Scholar
• Özcan A, Pehlivan M, Tomatir AG, et al. Polymorphisms of the DNA repair gene XPD (751) and XRCC1 (399) correlates with risk of hematological malignancies in Turkish population. Afri J Biotechnol. 2011;10(44):8860–8870. doi:10.5897/ajb10.1839
   Google Scholar
• Bănescu C, Iancu M, Trifa AP, et al. Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population. Tumor Biol. 2016;37(7):9357–9366. doi:10.1007/s13277-016-4815-6
   Google Scholar
• Shi JY, Ren ZH, Jiao B, et al. Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia. Int J Cancer. 2011;128(1):233–238. doi:10.1002/ijc.25318
   PubMed Web of Science ®Google Scholar
• Wen M, Zhou B, Lin X, et al. Associations between XPD Lys751Gln polymorphism and leukemia: a meta-analysis. Front Genet. 2018;9:1–11. doi:10.3389/fgene.2018.00218
   Web of Science ®Google Scholar
• Agrawal D, Gupta S, Agarwal D, Gupta OP, Agarwal M. Role of GSTM1 and GSTT1 polymorphism: susceptibility to oral submucous fibrosis in the north Indian population. Oncology. 2011;79(3–4):181–186. doi:10.1159/000318533
   Web of Science ®Google Scholar
• El-Tokhy MA, Hussein NA, Bedewy AML, Barakat MR. XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients. Hematology. 2014;19(7):397–403. doi:10.1179/1607845413Y.0000000144
   PubMed Web of Science ®Google Scholar
• Idris HME, Elderdery AY, Khalil HB, Mills J. Genetic polymorphism of GSTP1, GSTM1 and GSTT1 genes and susceptibility to chronic myeloid leukaemia. Asian Pacific J Cancer Prev. 2020;21(2):499–503. doi:10.31557/APJCP.2020.21.2.499
   PubMedGoogle Scholar
• Dincer Y, Yüksel S, Batar B, Güven M, Onaran I, Celkan T. DNA repair gene polymorphisms and their relation with DNA damage, DNA repair, and total antioxidant capacity in childhood acute lymphoblastic leukemia survivors. J Pediatr Hematol Oncol. 2015;37(5):344–350. doi:10.1097/MPH.0000000000000133
   Web of Science ®Google Scholar
• Muddathir ARM, Abdallah EI, Khabour OF, Abdelgader RE, Elgari MM. Age- and gender-independent association of glutathione S-transferase null polymorphisms with chronic myeloid leukemia. Bosn J Basic Med Sci. 2019;19(4):350–354. doi:10.17305/bjbms.2019.4176
   PubMed Web of Science ®Google Scholar
• Bajpai P, Tripathi AK, Agrawal D. Increased frequencies of glutathione-S-transferase (GSTM1 and GSTT1) null genotypes in Indian patients with chronic myeloid leukemia. Leuk Res. 2007;31(10):1359–1363. doi:10.1016/j.leukres.2007.02.003
   Web of Science ®Google Scholar
• Al-Achkar W, Azeiz G, Moassass F, Wafa A. Influence of CYP1A1, GST polymorphisms and susceptibility risk of chronic myeloid leukemia in Syrian population. Med Oncol. 2014;31(5):889. doi:10.1007/s12032-014-0889-4
   Web of Science ®Google Scholar
• Özten N, Sunguroǧlu A, Bosland MC. Variations in glutathione-S-transferase genes influence risk of chronic myeloid leukemia. Hematol Oncol. 2012;30(3):150–155. doi:10.1002/hon.1018
   Web of Science ®Google Scholar
• Lordelo GS, Miranda-Vilela AL, Akimoto AK, et al. Association between methylene tetrahydrofolate reductase and glutathione S-transferase M1 gene polymorphisms and chronic myeloid leukemia in a Brazilian population. Genet Mol Res. 2012;11(2):1013–1026. doi:10.4238/2012.April.19.6
   PubMed Web of Science ®Google Scholar
• Benescu C, Trifa AP, Voidezan S, et al. CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control study. Oxid Med Cell Longev. 2014;2014. doi:10.1155/2014/875861
   Web of Science ®Google Scholar
• Taspinar M, Aydos SE, Comez O, Elhan AH, Karabulut HG, Sunguroglu A. CYP1A1, GST gene polymorphisms and risk of chronic myeloid leukaemia. Swiss Med Wkly. 2008;138(1–2):12–17. doi:10.4414/smw.2008.12036
   Web of Science ®Google Scholar
• Hishida A, Terakura S, Emi N, et al. GSTT1 and GSTM1 deletions, NQO1 C609T polymorphism and risk of chronic myelogenous leukemia in Japanese. Asian Pacific J Cancer Prev. 2005;6(3):251–255.
   Google Scholar
• Weich N, Ferri C, Moiraghi B, et al. GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response. Cancer Epidemiol. 2016;44:16–21. doi:10.1016/j.canep.2016.07.008
   Web of Science ®Google Scholar
• Rostami G, Assad D, Ghadyani F, et al. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response. Mol Genet Genomic Med. 2019;7(7):1–10. doi:10.1002/mgg3.717
   Web of Science ®Google Scholar
• Shahrokhzadeh S, Soleimani A, Kordi-Tamandani DM, Sangtarash MH, Nejati O, Taheri M. Association of genetic polymorphisms in GSTP1, GSTM1, and GSTT1 genes with vesicoureteral reflux susceptibility in the children of southeast Iran. Iran J Public Health. 2020;49(7):1364–1371. doi:10.18502/ijph.v49i7.3591
   Web of Science ®Google Scholar
• He BS, Xu T, Pan YQ, et al. Nucleotide excision repair pathway gene polymorphisms are linked to breast cancer risk in a Chinese population. Oncotarget. 2016;7(51):84872–84882. doi:10.18632/oncotarget.12744
   PubMedGoogle Scholar
• Bănescu C, Trifa AP, Demian S, et al. Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia. Biomed Res Int. 2014;2014:213790. doi:10.1155/2014/213790
   Web of Science ®Google Scholar
• Mondal BC, Paria N, Majumdar S, et al. Glutathione S-transferase M1 and T1 null genotype frequency in chronic myeloid leukaemia. Eur J Cancer Prev. 2005;14(3):281–284. doi:10.1097/00008469-200506000-00014
   Web of Science ®Google Scholar
• Lourenc¸ GJ, Ortega MM, Nascimento H, et al. Polymorphisms of glutathione S -transferase in chronic myeloid leukaemia. Eur J Haematol. 2005;75:530–531. doi:10.1111/j.0902-4441.0000.t01-1-EJH2337.x
   Web of Science ®Google Scholar